Trial Profile
Immunologic Response to Influenza Vaccination in Children and Adolescents: A RCT Trial of Influenza Vaccines
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jul 2020
Price :
$35
*
At a glance
- Drugs Influenza vaccine (Optaflu) (Primary) ; Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 12 Jun 2020 Results published in the Vaccine.
- 07 Jan 2020 Status changed from active, no longer recruiting to completed.
- 01 May 2019 Status changed from recruiting to active, no longer recruiting.